Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

High androgen levels in young women with PCOS are linked to higher blood pressure.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Finasteride effectively treats hidradenitis suppurativa for most patients.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.